Becton Dickinson (BDX) Other financing activities (2009 - 2026)
Becton Dickinson (BDX) posted quarterly Other financing activities of $6.0 million for Q1 2026, down 91.78% year-over-year from $73.0 million in Q1 2025, and up 108.7% quarter-over-quarter from -$69.0 million in Q4 2025.
Becton Dickinson (BDX) Other financing activities (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Other financing activities for 18 consecutive years, with $6.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities fell 91.78% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at -$147.0 million (down 1030.77% YoY), while the FY2025 annual figure was -$87.0 million, up 2.25% from the prior year.
- Other financing activities rose to $6.0 million in Q1 2026 per BDX's latest filing, from -$69.0 million in the prior quarter.
- Across five years, Other financing activities topped out at $201.0 million in Q1 2022 and bottomed at -$215.0 million in Q2 2022.
- Historically, Other financing activities has averaged -$22.4 million across 5 years, with a median of -$9.0 million in 2024.
- On a YoY basis, Other financing activities climbed as much as 1057.14% in 2022 and fell as far as 2288.89% in 2022.
- Becton Dickinson's Other financing activities stood at -$89.0 million in 2022, then grew by 2.25% to -$87.0 million in 2023, then gained by 12.64% to -$76.0 million in 2024, then advanced by 9.21% to -$69.0 million in 2025, then soared by 108.7% to $6.0 million in 2026.
- Business Quant data shows BDX's Other financing activities at $6.0 million in Q1 2026, -$69.0 million in Q4 2025, and -$4.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn |
| 10 | Align Technology | 11.37 Bn | 10.27 Bn | 757.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -141.00 Mn |
| Jun 30, 2026 | -141.00 Mn |
| Mar 31, 2026 | 6.00 Mn |
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | -69.00 Mn |
| Dec 31, 2025 | -69.00 Mn |
| Sep 30, 2025 | -4.00 Mn |
| Sep 30, 2025 | -4.00 Mn |
| Jun 30, 2025 | -80.00 Mn |
| Jun 30, 2025 | -80.00 Mn |
| Mar 31, 2025 | 73.00 Mn |
| Mar 31, 2025 | 73.00 Mn |
| Dec 31, 2024 | -76.00 Mn |
| Dec 31, 2024 | -76.00 Mn |
| Sep 30, 2024 | -1.00 Mn |
| Sep 30, 2024 | -1.00 Mn |
| Jun 30, 2024 | -9.00 Mn |
| Jun 30, 2024 | -9.00 Mn |
| Mar 31, 2024 | 8.00 Mn |
| Mar 31, 2024 | 8.00 Mn |